We view Tenable as a solid cybersecurity vendor providing vulnerability management and security operations solutions to its clients. The firm’s combined portfolio delivers exposure management, ...
Hansa Biopharma reported its Q4 2024 earnings, revealing a larger-than-expected loss and lower-than-forecast revenue. The company posted an EPS of -4.08, significantly missing the forecast of -1.98, ...
Inc. reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.31, slightly above the forecast of $2.30. The company's ...
At this time, I'd like to welcome everyone to Envista Holdings Corporation's fourth quarter 2024 earnings results conference call. (Operator Instructions) I'll now turn the call over to Mr. Jim ...
Envista Holdings Corporation ( NYSE: NVST) Q4 2024 Earnings Conference Call February 5, 2025 5:30 PM ET Jim Gustafson – Vice President-Investor Relations Paul Keel – President and Chief Executive ...
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...
The gene-edited GMOs to be exempted are those classed as the products of SDN1 (gene disruption) and SDN2 (gene modification). As with the recent deregulation of gene-edited GMOs in England, the New ...